BA
PETX

BlackRock Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlackRock Advisors’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$442K Buy
61,529
+10,873
+21% +$87.9K ﹤0.01% 2272
2016
Q3 		$474K Buy
50,656
+34,741
+218% +$289K ﹤0.01% 2208
2016
Q2 		$101K Buy
15,915
+547
+4% +$3.52K ﹤0.01% 2962
2016
Q1 		$85K Buy
15,368
+2,959
+24% +$11.1K ﹤0.01% 2989
2015
Q4 		$69K Sell
12,409
-6,567
-35% -$43.4K ﹤0.01% 3086
2015
Q3 		$161K Sell
18,976
-23
-0.1% -$389 ﹤0.01% 2842
2015
Q2 		$287K Buy
18,999
+2,674
+16% +$38.6K ﹤0.01% 2577
2015
Q1 		$261K Buy
16,325
+2,375
+17% +$42.3K ﹤0.01% 2525
2014
Q4 		$249K Sell
13,950
-414
-3% -$5.16K ﹤0.01% 2485
2014
Q3 		$144K Buy
14,364
+4,105
+40% +$49.8K ﹤0.01% 2802
2014
Q2 		$160K Buy
10,259
+6,049
+144% +$85.7K ﹤0.01% 2779
2014
Q1 		$78K Sell
4,210
-17,384
-81% -$348K ﹤0.01% 3134
2013
Q4 		$412K Buy
21,594
+18,650
+633% +$379K ﹤0.01% 2171
2013
Q3 		$48K Buy
+2,944
New +$30.9K ﹤0.01% 3200

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's PETX Position: Q4 2016 in Review

BlackRock Advisors increased its Aratana Therapeutics, Inc. (PETX) stake by 21% in Q4 2016, buying an estimated $87.9K and bringing the position to 61,529 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

BlackRock Advisors first reported a position in PETX in Q3 2013 and has held it in 14 quarters since. The position peaked at $474K in Q3 2016. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • BlackRock Advisors held 61,529 shares of Aratana Therapeutics, Inc. worth $442K as of Q4 2016.
  • BlackRock Advisors bought 10,873 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $87.9K.
  • Aratana Therapeutics, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2272 holding.
  • BlackRock Advisors first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Advisors's Aratana Therapeutics, Inc. position peaked at $474K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.